Polianta Ltd’s CVS Health CVS Stock Holding History

Polianta Ltd’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,500	Closed	-$1.41M	–	82
2025 Q2	$1.41M	Buy	+20,500	New	+$1.34M	0.61%	26
2025 Q1	–	Sell	-23,700	Closed	-$1.06M	–	78
2024 Q4	$1.06M	Buy	23,700 +5,200	+28%	+$292K	0.51%	59
2024 Q3	$1.16M	Hold	18,500	–	–	0.55%	44
2024 Q2	$1.09M	Buy	+18,500	New	+$1.16M	0.55%	33
2023 Q4	–	Sell	-15,800	Closed	-$1.1M	–	75
2023 Q3	$1.1M	Hold	15,800	–	–	0.54%	25
2023 Q2	$1.09M	Buy	15,800 +1,500	+10%	+$107K	0.51%	35
2023 Q1	$1.06M	Buy	+14,300	New	+$1.2M	0.49%	54
2022 Q3	–	Sell	-8,000	Closed	-$741K	–	71
2022 Q2	$741K	Buy	+8,000	New	+$781K	0.63%	16
2018 Q4	–	Sell	-17,800	Closed	-$1.4M	–	67
2018 Q3	$1.4M	Buy	17,800 +1,000	+6%	+$71.5K	0.7%	22
2018 Q2	$1.08M	Hold	16,800	–	–	0.34%	67
2018 Q1	$1.04M	Hold	16,800	–	–	0.32%	70
2017 Q4	$1.22M	Buy	16,800 +3,400	+25%	+$247K	0.4%	49
2017 Q3	$1.09M	Hold	13,400	–	–	0.34%	66
2017 Q2	$1.08M	Buy	+13,400	New	+$1.06M	0.45%	53

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Polianta Ltd's CVS Position: Q3 2025 in Review

Polianta Ltd sold out of CVS Health (CVS) in Q3 2025, closing a stake of 20,500 shares — an estimated $1.41M sold.

Polianta Ltd first reported a position in CVS in Q2 2017 and held it in 14 quarters. The position peaked at $1.41M in Q2 2025. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

Polianta Ltd reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
Polianta Ltd sold 20,500 CVS Health shares in Q3 2025, an estimated $1.41M.
Polianta Ltd first reported a position in CVS Health in Q2 2017 and held it in 14 quarters.
Polianta Ltd's CVS Health position peaked at $1.41M in Q2 2025.
1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Polianta Ltd's 13F filing for Q3 2025, filed 16 Oct 2025.